Our Community

Continuing advances in cell and gene therapies (CGT) are transforming how biopharma companies develop treatments and potentially cures for certain diseases like cancer. Founded in 2019, the company uses technology that allows the integration of electronic and photonic structures on silicon substrates.

By means of synthetic biology and genetic code expansion, Valanx has developed a novel site-specific protein conjugation platform that allows precise control over conjugation site and number of conjugations on the protein of interest. Based on this platform, Valanx is developing a number of cutting-edge biologics towards potential treatments for various indications.

Solgate is a spinoff of the Centre for Molecular Medicine (CeMM) in Vienna and ISTA. The co-founders are leading edge researchers with deep knowledge of solute carrier biology through their coordinating role in the IMI RESOLUTE Consortium.

PRIME Aerostructures is an Austrian engineering company with a strong focus on the design, simulation and fabrication of state-of-the-art aviation and aerospace components.

Neurolentech is a spinoff of ISTA focused on personalized medicine for neurodevelopmental disorders. The company is developing and characterizing libraries of patient-derived neuronal cells, and will leverage this unique resource for the development of novel therapeutics to tackle severe forms of autism and epilepsy.

Tulon Photonics provides the next generation lasers to revolutionize 21st century photonics. 

Tulon's technology for laser tuning surpassed the best documented laser frequency stabilization using the current industry standard. It can be used in various ways, with the Laser being the most straightforward product.

Syntropic offers a non-invasive and non-pharmaceutical treatment for mental health disorders. Through light stimulation, neural remodeling is activated by instructing the immune cells of the brain to support in healing and recovery.

Syntropic is a clinical stage medical device company developing new technologies that enhance the brain’s neuroplasticity, allowing for the treatment of psychiatric disorders and the improvement of cognition.

 Syntropic's mission is to advance mental health care through the development of innovative technologies that target underlying causes of brain disorders.

Vertus energy has developed two technologies that have revolutionised the way the world is able to transform waste into energy. BRIO is a small but powerful unit that lives inside the anaerobic digester. BRIO allows AD plants to process three times more waste in the same sized tank while delivering biogas with 60% more energy potential than ever before.

The second technology, BODA, is carbon sequestration and conversion technology. BODA can either be used to “upgrade” the biogas from AD into Bio-methane or it can capture raw CO₂ and convert it into Renewable Natural Gas. BODA is a strong and powerful unit that eats CO₂ and H₂ to produce Renewable Natural Gas. 

Graph Therapeutics is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of patients are left without adequate treatment options - and AI trained with complex disease data can solve this.